Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
PIGW encodes a mannosyltransferase required for glycosylphosphatidylinositol (GPI) anchor biosynthesis. Biallelic PIGW variants cause hyperphosphatasia with intellectual disability syndrome 5, an autosomal recessive multisystem disorder characterized by elevated alkaline phosphatase, global developmental delay, developmental regression, and congenital anomalies including tetralogy of Fallot (HP:0001263, HP:0002376, HP:0001636).
Genetic evidence includes 16 unrelated probands with biallelic PIGW variants—missense and the first reported frameshift allele—across multiple families, supporting autosomal recessive inheritance and a loss-of-function mechanism (PMID:39766333). No large pedigrees for segregation analysis were reported. The variant spectrum comprises missense changes (e.g., c.199C>G (p.Pro67Ala)) and a novel frameshift (c.1112del (p.Ala372_Leu401del)) (PMIDs:30078644, 39924787).
Functional studies demonstrate significantly reduced cell surface expression of GPI-anchored proteins in patient granulocytes, lymphocytes, and monocytes by flow cytometry, confirming the pathogenicity of homozygous missense variants and supporting haploinsufficiency of PIGW ([PMID:30078644]). Additional in vitro assays of c.659T>G (p.Ile220Arg) and c.1112del (p.Ala372_Leu401del) recapitulate impaired GPI biosynthesis ([PMID:39924787]).
There are no reports disputing the association. The combined genetic and functional data provide strong evidence that PIGW loss of function underlies hyperphosphatasia with intellectual disability syndrome 5.
Key Take-home: Biallelic PIGW variants result in a severe, autosomal recessive GPI‐biosynthesis defect with characteristic hyperphosphatasia and neurodevelopmental impairment, enabling molecular diagnosis and informing management.
Gene–Disease AssociationStrong16 unrelated probands with biallelic PIGW variants and concordant clinical features (PMID:39766333) Genetic EvidenceStrong16 probands harboring missense and loss-of-function alleles across multiple families (PMID:39766333) Functional EvidenceModerateFlow cytometry and in vitro assays show decreased GPI-anchored protein expression and impaired enzyme function (PMIDs:30078644, 39924787) |